Dr. Alice S. Mims is the Acute Leukemia Clinical Research Director and Associate Professor in the Division of Hematology at Ohio State University Comprehensive Cancer Center - James. Dr. Mims is a hematologist who specializes in treating patients with acute and chronic myeloid diseases, particularly AML,
She earned her medical degree and Masters of Science in Clinical Research (MSCR) from the Medical University of South Carolina. Her research focuses on studying the effectiveness of novel therapeutics on patients with AML and other myeloid neoplasms including MDS. She is currently the lead principal investigator (PI) on a multi-center study investigating novel treatment in elder AML patients. Her presentation will include an update on her research and that of other promising treatments in the pipeline.
Dr. Mims will provide an overview of the latest treatment options in pipeline for High-Risk MDS and AML patients including several promising clinical trials that may be suitable for patients.
Participants will have an opportunity to ask questions via the text chat window. Those who are joining via telephone are invited to submit their questions to email@example.com in advance of the webinar.
Thank you for registering for "Advances in Treating High Risk MDS and AML", October 14, 2020 at 2pm Eastern.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone. If you do not receive the link,
please check your Spam/Junk folders.
If you have not received a registration confirmation, please email firstname.lastname@example.org
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.